JP2023506765A5 - - Google Patents

Info

Publication number
JP2023506765A5
JP2023506765A5 JP2022535453A JP2022535453A JP2023506765A5 JP 2023506765 A5 JP2023506765 A5 JP 2023506765A5 JP 2022535453 A JP2022535453 A JP 2022535453A JP 2022535453 A JP2022535453 A JP 2022535453A JP 2023506765 A5 JP2023506765 A5 JP 2023506765A5
Authority
JP
Japan
Prior art keywords
ankyrin repeat
designed ankyrin
repeat domain
acid sequence
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022535453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506765A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/085855 external-priority patent/WO2021116462A1/en
Publication of JP2023506765A publication Critical patent/JP2023506765A/ja
Publication of JP2023506765A5 publication Critical patent/JP2023506765A5/ja
Pending legal-status Critical Current

Links

JP2022535453A 2019-12-11 2020-12-11 変化した表面残基を有する設計されたアンキリン反復ドメイン Pending JP2023506765A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
EP19215435 2019-12-11
EP19215434.2 2019-12-11
EP19215433.4 2019-12-11
EP19215435.9 2019-12-11
EP19215433 2019-12-11
EP19215436 2019-12-11
EP19215434 2019-12-11
EP19215436.7 2019-12-11
EP20161059 2020-03-04
EP20161059.9 2020-03-04
EP20181234 2020-06-19
EP20181234.4 2020-06-19
PCT/EP2020/085855 WO2021116462A1 (en) 2019-12-11 2020-12-11 Designed ankyrin repeat domains with altered surface residues

Publications (2)

Publication Number Publication Date
JP2023506765A JP2023506765A (ja) 2023-02-20
JP2023506765A5 true JP2023506765A5 (cg-RX-API-DMAC7.html) 2023-12-18

Family

ID=73790118

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022535453A Pending JP2023506765A (ja) 2019-12-11 2020-12-11 変化した表面残基を有する設計されたアンキリン反復ドメイン
JP2022535443A Active JP7794740B2 (ja) 2019-12-11 2020-12-11 組換えペプチド-mhc複合体結合タンパク質並びにそれらの生成及び使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022535443A Active JP7794740B2 (ja) 2019-12-11 2020-12-11 組換えペプチド-mhc複合体結合タンパク質並びにそれらの生成及び使用

Country Status (11)

Country Link
US (4) US20220106707A1 (cg-RX-API-DMAC7.html)
EP (2) EP4073091A1 (cg-RX-API-DMAC7.html)
JP (2) JP2023506765A (cg-RX-API-DMAC7.html)
KR (2) KR20220113491A (cg-RX-API-DMAC7.html)
CN (2) CN115003689A (cg-RX-API-DMAC7.html)
AU (2) AU2020402581A1 (cg-RX-API-DMAC7.html)
BR (2) BR112022011177A2 (cg-RX-API-DMAC7.html)
CA (2) CA3161321A1 (cg-RX-API-DMAC7.html)
IL (2) IL293698A (cg-RX-API-DMAC7.html)
MX (2) MX2022007122A (cg-RX-API-DMAC7.html)
WO (2) WO2021116469A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
MX2022013945A (es) 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
EP3957649A1 (en) * 2020-08-18 2022-02-23 Athebio AG Improved n-terminal capping modules of ankyrin repeat domains
US11981710B2 (en) 2020-08-18 2024-05-14 Athebio Ag N-terminal capping modules of ankyrin repeat domains
US12435444B2 (en) 2021-03-09 2025-10-07 Cdr-Life Ag Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
EP4387984A1 (en) * 2021-08-17 2024-06-26 Athebio AG Variants of ankyrin repeat domains
WO2023021050A1 (en) * 2021-08-17 2023-02-23 Athebio Ag Variants of ankyrin repeat domains
EP4137508A1 (en) * 2021-08-17 2023-02-22 Athebio AG Variants of ankyrin repeat domains
WO2023110983A1 (en) 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
CA3240046A1 (en) * 2021-12-14 2023-06-22 Cdr-Life Ag Dual mhc-targeting t cell engager
CA3262553A1 (en) 2022-08-01 2024-02-08 Molecular Partners Ag REHEARSAL AREAS DESIGNED WITH MODIFIED CHARGES AND THEIR USE
EP4587046A1 (en) 2022-09-14 2025-07-23 CDR-Life AG Mage-a4 peptide dual t cell engagers
EP4673159A1 (en) 2023-02-27 2026-01-07 Molecular Partners AG Darpins for use in reducing renal accumulation of drugs
EP4694904A2 (en) 2023-04-13 2026-02-18 REGENXBIO Inc. Targeting aav capsids, methods of manufacturing and using same
WO2024251628A1 (en) * 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
WO2025163082A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025163144A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
DE202024101891U1 (de) 2024-04-16 2025-07-18 Igus Gmbh Leitungsführungsvorrichtung für Reinraumanwendungen sowie Halteelement dafür
WO2025250756A2 (en) * 2024-05-30 2025-12-04 Aethon Therapeutics, Inc. Compositions and methods for binding to covalent peptide conjugates containing divarasib
WO2026093563A2 (en) 2024-10-31 2026-05-07 Molecular Partners Ag Multispecific binding proteins and their use
WO2026150109A1 (en) 2025-01-10 2026-07-16 Molecular Partners Ag Mesothelin-specific binding constructs and their use in radiotherapy

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
AU2003216341A1 (en) 2002-02-20 2003-09-09 Dyax Corporation Mhc-peptide complex binding ligands
KR20070085314A (ko) 2004-11-12 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 재조합 뉴캐슬 질환 바이러스
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
HUE025636T2 (en) 2007-07-27 2016-04-28 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
WO2012149439A2 (en) * 2011-04-29 2012-11-01 Janssen Biotech, Inc. Il4/il13 binding repeat proteins and uses
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2906591A1 (en) 2012-10-15 2015-08-19 Universität Zürich Bispecific her2 ligands for cancer therapy
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
ES2740930T3 (es) 2014-03-14 2020-02-07 Immunocore Ltd Bibliotecas de TCR
US20170226158A1 (en) * 2014-08-11 2017-08-10 Medimmune Limited Intracellular antigen binding
EP3286222A4 (en) 2015-03-23 2018-08-08 The Johns Hopkins University Hla-restricted epitopes encoded by somatically mutated genes
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
JP7599819B2 (ja) 2016-06-02 2024-12-16 イムノコア リミテッド gp100特異的TCR-抗CD3 scFv融合タンパク質の投薬レジメン
MY196882A (en) 2016-09-22 2023-05-08 Molecular Partners Ag Recombinant binding proteins and their use
US12065479B2 (en) * 2017-11-16 2024-08-20 The Regents Of The University Of California Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof
CA3139164A1 (en) 2019-06-04 2020-12-10 Molecular Partners Ag Recombinant fap binding proteins and their use
EP3980452A1 (en) 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
JP2022535564A (ja) 2019-06-04 2022-08-09 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
KR20220016944A (ko) 2019-06-04 2022-02-10 몰리큘라 파트너스 아게 개선된 안정성을 갖는 설계된 안키린 반복 도메인
CN114945584A (zh) 2019-12-11 2022-08-26 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
AU2020402581A1 (en) * 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
MX2022013945A (es) * 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
AU2021271131A1 (en) 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use

Similar Documents

Publication Publication Date Title
JP4180590B2 (ja) クレブシエラ・ニューモニエ由来の免疫アジュバントタンパク質
JP2001514858A5 (cg-RX-API-DMAC7.html)
JP2010516758A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
JP2010516290A5 (cg-RX-API-DMAC7.html)
CA2299677A1 (en) Preparation and use of recombinant influenza a virus m2 constructs and vaccines
JP2023554379A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
JP2024508683A5 (cg-RX-API-DMAC7.html)
JP2024533316A5 (cg-RX-API-DMAC7.html)
JP2024535925A5 (cg-RX-API-DMAC7.html)
JP2024513559A5 (cg-RX-API-DMAC7.html)
JP2024503091A5 (cg-RX-API-DMAC7.html)
JP2023542453A5 (cg-RX-API-DMAC7.html)
JP2023522154A5 (cg-RX-API-DMAC7.html)
CN104755619A (zh) 用于预防猪水肿病的疫苗
JPH01160998A (ja) ポリペプチド
CN115850520A (zh) 新型结核病亚单位疫苗al的制备方法和应用
JPH10508479A (ja) 天然疎水性ペプチドアナログとしての組換えペプチドの産生
JP4005633B2 (ja) F型ボツリヌス毒素およびその用途
US20250042962A1 (en) Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use
JPH06511154A (ja) 組換えBorreliaタンパクの製造法
Holtet et al. Receptor‐binding domain of human α2‐macroglobulin Expression, folding and biochemical characterization of a high‐affinity recombinant derivative
DK200800635A (da) Hidtil ukendt fiskelusvaccine.
ES2260416T3 (es) Polipeptido que induce anticuerpos que neutralizan el vih.